Abu Dhabi MGX backs $2.1 billion funding for UK’s Isomorphic Labs

On 2026-05-20, Abu Dhabi-based MGX joined a $2.1 billion Series B funding round for UK drug design company Isomorphic Labs. The fresh capital is intended to support global scaling, hiring, and continued development of its AI drug design engine. Alphabet, Google Ventures, Temasek, CapitalG, and the UK Sovereign AI Fund also participated.